Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Schwartz, C. E.
Right arrow Articles by LaRocca, N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Schwartz, C. E.
Right arrow Articles by LaRocca, N.
Neurology 1999;52:626
© 1999 American Academy of Neurology
Brief Communications

Utilization of unconventional treatments by persons with MS: Is it alternative or complementary?

Carolyn E. Schwartz, ScD, Elissa Laitin, SM, Sally Brotman, MSS and Nicholas LaRocca, PhD

From the Behavioral Science Research Program (Dr. Schwartz, and E. Laitin and S. Brotman), Frontier Science & Technology Research Foundation, Chestnut Hill, MA; the Department of Psychiatry (Dr. Schwartz), Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA; and Health Care Delivery and Policy Research Program (Dr. LaRocca), National Multiple Sclerosis Society, New York, NY. Funding was provided by the Health Care Delivery and Policy Research Program of the National Multiple Sclerosis Society (HS0104) and the Agency for Health Care Policy and Research (R01 HS08582).

Address correspondence and reprint requests to Dr. Carolyn Schwartz, Frontier Science, 1244 Boylston St., Ste. 303, Chestnut Hill, MA 02467-2104; e-mail: schwartz{at}jimmy.harvard.edu

This cross-sectional mail survey evaluated the prevalence and predictors of unconventional therapy (UT) utilization among 569 community-based people with MS. One-third reported having visited a UT practitioner in the last 6 months. Utilizers tended to report at least one medical comorbidity, earn at least $50,000 a year, and engage in preventive health behaviors; they also used more outpatient services and reported higher levels of interpersonal quality of care with their allopathic MS care provider than did nonutilizers. We conclude that UT is complementary to allopathic medicine for people with MS.




This article has been cited by other articles:


Home page
 Integr Cancer TherHome page
V. S. Eschiti
Lesson From Comparison of CAM Use by Women With Female-Specific Cancers to Others: It's Time to Focus on Interaction Risks With CAM Therapies
Integr Cancer Ther, December 1, 2007; 6(4): 313 - 344.
[Abstract] [PDF]

Home page
 Mult SclerHome page
L Shinto, V Yadav, C Morris, J A Lapidus, A Senders, and D Bourdette
Demographic and health-related factors associated with complementary and alternative medicine (CAM) use in multiple sclerosis
Multiple Sclerosis, February 1, 2006; 12(1): 94 - 100.
[Abstract] [PDF]

Home page
 J. Neurol. Neurosurg. PsychiatryHome page
A Croquelois, G Assal, J-M Annoni, F Staub, A Gronchi, L Bruggimann, S Dieguez, and J Bogousslavsky
Diseases of the nervous system: patients' aetiological beliefs
J. Neurol. Neurosurg. Psychiatry, April 1, 2005; 76(4): 582 - 584.
[Abstract] [Full Text] [PDF]

Home page
 Mult SclerHome page
S. Schwarz and H. Leweling
Multiple sclerosis and nutrition
Multiple Sclerosis, February 1, 2005; 11(1): 24 - 32.
[Abstract] [PDF]

Home page
 Complementary Health Practice ReviewHome page
M. Hussain-Gambles and P. Tovey
The Experience of Complementary Alternative Medicine Use among People with Multiple Sclerosis
Complementary Health Practice Review, January 1, 2004; 9(1): 21 - 30.
[Abstract] [PDF]

Home page
 Mult SclerHome page
R. A. Marrie, O. Hadjimichael, and T. Vollmer
Predictors of alternative medicine use by multiple sclerosis patients
Multiple Sclerosis, October 1, 2003; 9(5): 461 - 466.
[Abstract] [PDF]

Home page
 Mult SclerHome page
I Siev-Ner, D Gamus, L Lerner-Geva, and A Achiron
Refiexology treatment relieves symptoms of multiple sclerosis: a randomized controlled study
Multiple Sclerosis, August 1, 2003; 9(4): 356 - 361.
[Abstract] [PDF]

Home page
 Mult SclerHome page
J. Sastre-Garriga, E. Munteis, J. Rio, I. Pericot, M. Tintore, and X. Montalban
Unconventional therapy in multiple sclerosis
Multiple Sclerosis, June 1, 2003; 9(3): 320 - 322.
[Abstract] [PDF]

Home page
 Clin RehabilHome page
S. Nayak, R. J Matheis, N. E Schoenberger, and S. C Shiflett
Use of unconventional therapies by individuals with multiple sclerosis
Clinical Rehabilitation, February 1, 2003; 17(2): 181 - 191.
[Abstract] [PDF]

Home page
 NeurologyHome page
P. R. Rajendran, R. E. Thompson, and S. G. Reich
The use of alternative therapies by patients with Parkinson's disease
Neurology, September 11, 2001; 57(5): 790 - 794.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurol. Neurosurg. PsychiatryHome page
A. A Fisher and D. G Le Couteur
Lead poisoning from complementary and alternative medicine in multiple sclerosis
J. Neurol. Neurosurg. Psychiatry, November 1, 2000; 69(5): 687 - 689.
[Abstract] [Full Text] [PDF]

Home page
 Neurorehabil Neural RepairHome page
C. S. Berkman, M. G. Pignotti, P. F. Cavallo, and N. J. Holland
Use of Alternative Treatments by People with Multiple Sclerosis
Neurorehabil Neural Repair, December 1, 1999; 13(4): 243 - 254.
[Abstract] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1999 by AAN Enterprises, Inc.